Transforming cisplatin into targeted photothermal chemotherapeutics through the platinum-phosphate coordination within a hyaluronan nanogel
Yiyi Zhang, Huimin Wang, Hua Guo, Xiaorong Gou, Xinxin Hao, Jiayi Li, Hong Deng, Weiqi Zhang
TL;DR
This paper presents a new nanogel that turns cisplatin into a targeted and less toxic cancer treatment by combining chemotherapy with photothermal therapy.
Contribution
A novel HA nanogel using platinum-phosphate coordination to enable targeted photothermal chemotherapy with cisplatin.
Findings
The HA/PtP nanogel achieves 32.08% photothermal conversion efficiency.
The nanogel releases cisplatin under acidic conditions through reversible Pt-phos interactions.
It shows effective tumor targeting and reduced toxicity in mouse models.
Abstract
Cisplatin’s (Cis’s) antitumor efficacy is limited by dose-dependent toxicity due to nonspecific tissue distribution. While targeted Cis delivery and combination therapies boost therapeutic efficacy, developing multifunctional yet simplified formulations remains challenging. Inspired by the Cis’s interaction with DNA, here, we transformed Cis into a reversible photothermal agent through the platinum-phosphate (Pt-phos) interaction within a hyaluronan (HA) nanogel (named as HA/PtP) to afford synergistic photothermal therapy (PTT) and chemotherapy. The HA/PtP nanogel exhibits near infrared absorption and 32.08% photothermal conversion efficiency, and degrades to release Cis through the reversible Pt-phos interaction under acidic conditions. Leveraging HA’s intrinsic CD44 targeting, HA/PtP nanogel simultaneously enables highly efficient PTT and targeted chemotherapy in 4T1 breast tumor…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Intraperitoneal and Appendiceal Malignancies